__NUXT_JSONP__("/drugs/Liarozole_Hydrochloride", (function(a,b,c){return {data:[{drug:{slug:a,emaEpar:[],fdaDrugLabel:[],id:a,nciThesaurus:{casRegistry:"145858-50-0",chebiId:"",chemicalFormula:"C17H13ClN4.HCl",definition:"The fumarate salt of an orally-active benzimidazole derivative with potential antineoplastic activity. As a retinoic acid metabolism blocking agent (RAMBA), liarozole inhibits cytochrome P450-dependent all-trans-retinoic acid (ATRA)-4-hydroxylase, resulting in an increase in endogenous ATRA production, inhibition of cell proliferation, and induction of cell differentiation. This agent also inhibits aromatase, the enzyme that catalyzes the final, rate-limiting step in estrogen biosynthesis.",fdaUniiCode:"29T7S2IB97",identifier:"C80333",preferredName:b,semanticType:"Organic Chemical",subclassOf:["C2018"],synonyms:["(+-)-5-(m-Chloro-alpha-imidazol-1-ylbenzyl)benzimidazole Monohydrochloride","1H-Benzimidazole, 5-((3-chlorophenyl)-1H-imidazol-1-ylmethyl)-, Monohydrochloride, (+-)-","LIAROZOLE HYDROCHLORIDE","Liarozole HCl",b,"R 75251"]},dir:"\u002Fdrugs",path:"\u002Fdrugs\u002FLiarozole_Hydrochloride",extension:".json",createdAt:c,updatedAt:c}}],fetch:{},mutations:void 0}}("Liarozole_Hydrochloride","Liarozole Hydrochloride","2021-10-30T13:45:40.613Z")));